Letter to the Editor October 15, 2007

Remission of Panic Disorder With Mirtazapine Augmentation of Paroxetine: A Case Report

Prim Care Companion J Clin Psychiatry 2007;9(5):396

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Paroxetine is a selective serotonin reuptake inhibitor(SSRI) antidepressant with proven efficacy in the short- andlong-term treatment of panic attacks with or without agoraphobia.1 Mirtazapine is a noradrenergic and specific serotonergicantidepressant that acts by antagonizing the adrenergic α2-autoreceptorsand α2-heteroreceptors, as well as by blocking serotonin5-HT2 and 5-HT3 receptors. It enhances, therefore, therelease of norepinephrine and 5-HT1A-mediated serotonergictransmission.